BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37160627)

  • 21. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction and validation of a SEER-based prognostic nomogram for young and middle-aged males patients with hepatocellular carcinoma.
    Yang R; Yu X; Zeng P
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10099-10108. PubMed ID: 37266663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
    Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
    Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
    Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study.
    Hao S; Luo R; Li W; Zhao R; Qi T; Wang Z; Li N; Liu M
    BMC Gastroenterol; 2023 Jun; 23(1):207. PubMed ID: 37312022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma.
    Guan R; Lin W; Zou J; Mei J; Wen Y; Lu L; Guo R
    Cancer Control; 2022; 29():10732748221102820. PubMed ID: 35609265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.
    Zhou D; Liu X; Wang X; Yan F; Wang P; Yan H; Jiang Y; Yang Z
    BMC Cancer; 2021 Mar; 21(1):246. PubMed ID: 33685417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a nomogram for predicting the cancer-specific survival of fibrolamellar hepatocellular carcinoma patients.
    Hu J; Wang Y; Deng L; Yu H; Chen K; Bao W; Chen K; Chen G
    Updates Surg; 2022 Oct; 74(5):1589-1599. PubMed ID: 35713784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.
    Hu C; Yang J; Huang Z; Liu C; Lin Y; Tong Y; Fan Z; Chen B; Wang C; Zhao CL
    BMC Cancer; 2020 Jun; 20(1):494. PubMed ID: 32487048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.
    Zhang Q; Ning G; Jiang H; Huang Y; Piao J; Chen Z; Tan X; Zhang J; Liu G
    Dis Markers; 2020; 2020():9180732. PubMed ID: 33520012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

  • 32. The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.
    Liu W; Zhang F; Quan B; Li M; Lu S; Li J; Chen R; Yin X
    Dis Markers; 2021; 2021():3514827. PubMed ID: 34840628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A practical nomogram from the SEER database to predict the prognosis of hepatocellular carcinoma in patients with lymph node metastasis.
    Zhang K; Tao C; Wu F; Wu J; Rong W
    Ann Palliat Med; 2021 Apr; 10(4):3847-3863. PubMed ID: 33752423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel nomogram based on the hematological prognosis risk scoring system can predict the overall survival of patients with hepatocellular carcinoma.
    Lei K; Deng Z; Wang J; Wang H; Hu R; Li Y; Wang X; Xu J; You K; Liu Z
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14631-14640. PubMed ID: 37584710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment and validation of a prognostic pomogram in unresectable hepatocellular carcinoma treated with intensity modulated radiotherapy: a real world study.
    Long M; Li J; He M; Qiu J; Zhang R; Liu Y; Liang C; Lu H; Pang Y; Zhou H; Yu H; Qiu M
    Radiat Oncol; 2023 Jun; 18(1):96. PubMed ID: 37287040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
    Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
    Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma.
    Wan G; Gao F; Chen J; Li Y; Geng M; Sun L; Liu Y; Liu H; Yang X; Wang R; Feng Y; Wang X
    BMC Cancer; 2017 Jan; 17(1):91. PubMed ID: 28143427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Validation of a Nomogram to Predict Cancer-Specific Survival for Middle-Aged Patients With Early-Stage Hepatocellular Carcinoma.
    Wen C; Tang J; Luo H
    Front Public Health; 2022; 10():848716. PubMed ID: 35296046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.